Cite
Paternoster M, Steichen O, Lapeyre-Mestre M, et al. Risk of bleeding associated with nonsteroidal anti-inflammatory drug use in patients exposed to antithrombotic therapy: a case-crossover study. J Clin Pharmacol. 2021;doi: 10.1002/jcph.2003.
Paternoster, M., Steichen, O., Lapeyre-Mestre, M., Blanchon, T., Rossignol, L., Vilcu, A. M., Launay, T., Sarazin, M., Bagheri, H., Conte, C., Turbelin, C., Hanslik, T., & Souty, C. (2021). Risk of bleeding associated with nonsteroidal anti-inflammatory drug use in patients exposed to antithrombotic therapy: a case-crossover study. Journal of clinical pharmacology, . https://doi.org/10.1002/jcph.2003
Paternoster, Morgane, et al. "Risk of bleeding associated with nonsteroidal anti-inflammatory drug use in patients exposed to antithrombotic therapy: a case-crossover study." Journal of clinical pharmacology vol. (2021). doi: https://doi.org/10.1002/jcph.2003
Paternoster M, Steichen O, Lapeyre-Mestre M, Blanchon T, Rossignol L, Vilcu AM, Launay T, Sarazin M, Bagheri H, Conte C, Turbelin C, Hanslik T, Souty C. Risk of bleeding associated with nonsteroidal anti-inflammatory drug use in patients exposed to antithrombotic therapy: a case-crossover study. J Clin Pharmacol. 2021 Nov 17; doi: 10.1002/jcph.2003. Epub 2021 Nov 17. PMID: 34787325.
Copy
Download .nbib